NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
Sponsor
Boehringer Ingelheim